Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03483662 · ClinicalTrials.gov registry record · NA
Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS)
A NA study, sponsored by Tulane University.
- Completed
- Registry status
- NA
- Development phase
- 1,272
- Enrollment target
NCT03483662: Completed NA study, sponsored by Tulane University.
NCT03483662 is a NA study that has completed, run by Tulane University. The registered enrollment target is 1,272 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03483662, a NA study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,272 participants
- Enrollment target
Study Summary
The IMPACTS study utilizes an effectiveness-implementation hybrid type 2 design to achieve two primary goals simultaneously: 1). to test the effectiveness of a multifaceted implementation strategy for intensive BP control among underserved hypertensive patients at high risk for CVD, and 2). to assess the implementation outcomes of the multifaceted implementation strategy in patients and providers.
Primary Outcome
The primary outcome is the difference in mean change of systolic blood pressure from baseline to 18 months between intervention and control groups. Blood pressure will be measured 3 times each at two baseline, one 6-month, one 12-month, and two termination visits according to a standard protocol.
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Multicomponent Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,272 participants |
| Start Date | 2018-06-27 |
| Est. Completion | 2024-02-15 |
| Phase | NA |
What the finished NCT03483662 record still lists
NCT03483662 is an interventional study that assigns participants to a tested intervention. Its 1,272 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT03483662 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03483662 about?
NCT03483662 is a clinical study titled "Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS)". The IMPACTS study utilizes an effectiveness-implementation hybrid type 2 design to achieve two primary goals simultaneously: 1). to test the effectiveness of a multifaceted implementation strategy for intensive BP control among underserved hypertensive patients at high risk for CVD, and 2). to asses...
What is the current status of trial NCT03483662?
This trial is currently completed. It is a NA study. The enrollment target is 1,272 participants. The study started on 2018-06-27. Estimated completion is 2024-02-15.
What interventions are being tested in trial NCT03483662?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Multicomponent Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03483662?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03483662's enrollment target sits among peer trials
1,272 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03678025 · 1,273 participants · Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
- NCT06876246 · 1,270 participants · NA
SBIR/ STTR Family Check-up Online
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI